Adjuvant pembrolizumab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Adjuvant pembrolizumab
Apr 23, 2024, 05:35 |
Blog
Sergio Cifuentes: My insights on a recent study Keynote A18 from The Lancet, Domenica Lorusso and Ana Oaknin
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X/Twitter: "My insights on a…
Apr 20, 2024, 20:30 |
Insight
Tom Powles: Adjuvant pembrolizumab in clear cell renal cancer for the 1st time (KN564)
Tom Powles, Director of Barts Cancer Center, recently shared on X: "Adjuvant pembrolizumab shows a…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Jan 13, 2024, 12:21 |
Blog
Maite Bourlon: Adjuvant pembrolizumab is SOC for high-risk resected RCC
Maite Bourlon, the Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube